Scientists at EPFL have developed "lymphomoids," a pioneering cancer model that preserves the structure and multicellular ...

A groundbreaking innovation in cancer treatment is emerging, offering a glimpse into a future of safer, more effective ...

Predictive cancer diagnostics company Rhythm Biosciences (ASX:RHY) is ending 2024 on a high reporting it has attained all key ...

Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...

The study is led by professor Stephen Kent from the University of Melbourne and laboratory head at the Doherty Institute ...